Bernard J. Gersh works in Cross-Cutting Cardiology affiliated with Mayo Clinic.
Bernard J. Gersh, M.B., Ch.B., D.Phil., is Professor of Medicine at Mayo Clinic College of Medicine and Science and a consultant in cardiovascular diseases and internal medicine in Rochester, Minnesota. He is also an Adjunct Professor in the Department of Medicine at Duke University. He previously served as Chief of the Division of Cardiology and the W. Proctor Harvey Teaching Professor of Cardiology at Georgetown University Medical Center.
1,803 pubs · 143,508 cites · h-index 174
MB ChB
University of Cape Town
1965
D.Phil.
University of Oxford
1970
Professor of Medicine
Mayo Clinic College of Medicine and Science · 1999 - Present
Adjunct Professor in the Department of Medicine
Duke University · 2017 - Present
Emeritus, Department of Cardiovascular Medicine
Mayo Clinic · 2016 - Present
Chief, Division of Cardiology
Georgetown University Medical Center · 1993 - 1998
Consultant, Division of Cardiovascular Diseases
Mayo Clinic · 1979 - 1993
Cardiac Imaging · Harvard University
A calcium score of zero is reassuring, but it does not mean that someone has no risk of a future heart attack. Our study shows that inflammation can reveal risk that calcium scoring alone may miss.
JAMA CardiologyChan et al.
Electrophysiology · Apple (Israel)
Traditional screening programs select patients based on age (65 or older) or the presence of conditions such as high blood pressure. These approaches make sense because advanced age is one of the most important risk factors for atrial fibrillation. However, it is not feasible to repeatedly conduct intensive heart monitoring in more than 50 million older adults across the country. The study shows that an AI algorithm can select a subgroup of older adults who might benefit more from intensive monitoring.
The LancetNoseworthy et al.
Interventional / Structural Cardiology · Westchester Medical Center
In many of the shock states, like septic shock or postcardiotomy shock, it’s very well established, but there is limited data with cardiogenic shock. For the longest time as cardiologists, we believed the problem was the coronaries and if we fix the coronaries these patients will get better. Unfortunately, nearly 45% of patients who have their coronaries fixed and have normal central hemodynamics still die. So clearly there is an additional insult in the form of microcirculatory abnormalities.
Journal of the American College of CardiologyVallabhajosyula et al.
JACCTsang et al.cohort
LA volume may better predict events than area or diameter in sinus rhythm; leaves open routine preference pending validation.
Heart RhythmGoings et al.cohort
May aid risk stratification in new-onset LBBB; extends AI-ECG associations but hypothesis-generating pending prospective validation.
JACCSorajja et al.cohort
Hypothesis-generating for myocardial bridging in HCM; prospective studies needed before clinical adoption.
Blood Pressure and Hypertension Studies · Sprint (United States)
If you decrease the BP too low, then the flow of blood in the coronary arteries and the oxygen supply to the myocardium will decline. In patients with CAD and the elderly, diastole is the time when the myocardium fills with blood. Caution should be observed in lowering the diastolic BP in patients with CAD or in elderly patients who presumably have more atheroma than younger patients, and the physician should be alert to signs of ischemia as the BP goes down. The diastolic BP should not really be lowered below about 60 mm Hg.
Journal of the American College of CardiologyRosendorff et al.
Electrophysiology · Mayo Clinic in Arizona
In general, patients with atrial fibrillation taking blood-thinning medications tend to have declining kidney function over time. However, our findings indicate that the non-vitamin K antagonist oral anticoagulants as a group are associated with less injury to kidneys than warfarin.
Journal of the American College of CardiologyYao et al.
JACCGeske et al.review
This review outlines the pathophysiology, hemodynamics, diagnostic assessment, and therapeutic approach needed to critically distinguish between potentially curable constrictive pericarditis and restrictive cardiomyopathy.
CirculationFreedman et al.editorial
The increasing prevalence of atrial fibrillation in older adults highlights a growing public health burden and the critical need for effective stroke prevention strategies.
Electrophysiology · Boston Children's Hospital
A very common clinical scenario is that someone comes to the hospital with an ischemic stroke, and we want to know whether they have atrial fibrillation. We have done previous work using neural networks, machine learning, that found that it was extremely powerful in detecting subtle patterns [in ECG tracings], and we wondered: If someone had atrial fibrillation yesterday, is there any way that it might leave a trace of a finding on an ECG today that's too subtle for a human to read but a computer could pick up?
The LancetAttia et al.
LancetHeusch et al.review
Supports early reperfusion and targeted therapies in CAD and HF; extends mechanistic models to guide future targeted interventions.
JACCChugh et al.review
May guide future AF research priorities; leaves open whether molecular insights should alter current management.
Atrial Fibrillation Management and Outcomes · Broad Institute
These data indicate that familial AF is genetically heterogeneous and that at least two disease genes are responsible for this disorder
Journal of the American College of CardiologyDarbar et al.
JACCTsang et al.Case-Control Study
Case-control study observes elevated atrial fibrillation prevalence in incident stroke patients, highlighting cardiac arrhythmia as a major stroke risk factor.
JACCCasaclang‐Verzosa et al.review
Understanding and targeting the mechanisms of left atrial remodeling may offer therapeutic strategies to prevent or attenuate the progression of atrial fibrillation.
JACCDavidson et al.Guideline
This review by the American College of Cardiology outlines a practical approach to left main coronary artery disease. The authors propose an algorithm that uses medical therapy alone or alongside a stent or bypass surgery. They recommend a heart team approach that accounts for clinical factors and relies on shared decision making.
JACCMadhavan et al.systematic_review
Supports frailty-informed CAD decisions now; leaves open dedicated RCTs given systematic underrepresentation of adults ≥80.
JACCHueb et al.RCT
In patients with stable multivessel CAD and preserved ventricular function, CABG provides superior angina relief at 1 year, while medical therapy yields excellent survival and fewer short-term events compared to PCI.
